Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -440.68% | 79.50% | -6.24% | 9.37% | 90.16% |
| Total Depreciation and Amortization | 11.11% | -12.48% | 5.61% | 101.23% | -195.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.35% | -576.60% | -21.60% | -96.88% | 3,118.73% |
| Change in Net Operating Assets | -288.97% | -57.67% | 133.65% | 182.85% | -62.17% |
| Cash from Operations | 20.38% | -134.36% | -1.94% | 36.32% | 33.32% |
| Capital Expenditure | 48.90% | -253.43% | -1,101.16% | 115.64% | 60.40% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 475.08% | -141.27% | 42.91% | -27.16% | -44.59% |
| Cash from Investing | 11.75% | 37.77% | 37.71% | -25.24% | -44.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -82.25% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -82.25% | -- | -100.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.14% | -206.25% | 318.27% | 140.64% | -230.51% |